HIV prevention at your doorstep: study tests community PrEP delivery
NCT ID NCT06176859
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study tests whether delivering HIV prevention medication (PrEP) directly in communities is better than requiring clinic visits. About 2,500 young people in South Africa will receive PrEP either at a clinic or through a community-based service. The goal is to see if community delivery increases PrEP use and makes prevention easier and more accessible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Human Sciences Research Council
Durban, KwaZulu-Natal, South Africa
Conditions
Explore the condition pages connected to this study.